Day: July 3, 2024

Dore Copper Enters Into an Agreement to Acquire Claims Next to Its Flagship Corner Bay High-Grade Copper Deposit

TORONTO, July 03, 2024 (GLOBE NEWSWIRE) — Doré Copper Mining Corp. (the “Company” or “Doré Copper“) (TSXV: DCMC; OTCQB: DRCMF; FRA: DCM) is pleased to announce it has entered into an agreement with SOQUEM to acquire a 56.41% interest in a group of contiguous claims (the “Claim Group”) located immediately north and east of its flagship high-grade Corner Bay copper project in the Chibougamau mining camp, approximately 55 kilometers by road from Chibougamau, Québec. The Claim Group totals 17 claims covering an area of 446 ha within Dore Copper’s 100% owned Corner Bay-Devlin Property (5,446 ha) (Figure 1). The Claim Group has seen historical exploration during the 1970’s with 36 diamond drill holes totaling approximately 7,610 meters. Further exploration activities was carried out by SOQUEM between 1992...

Continue reading

AMERICAN SALARS TO INCORPORATE ARGENTINA BASED “MINING COMPANY” SUBSIDIARY FOR POCITOS SALAR PROJECT

VANCOUVER, BC, July 03, 2024 (GLOBE NEWSWIRE) — AMERICAN SALARS LITHIUM INC. (“AMERICAN SALARS” OR THE “COMPANY”) (CSE: USLI, OTC: ASALF, FWB: Z3P, WKN: A3E2NY) announces the Company is registering a mining company in Argentina operating under the name “American Salars Pocitos SA”, a 100% owned subsidiary of American Salars, a crucial next step as the Company matures from the acquisition, discovery and delineation of inferred mineral resources, to the establishment of measured and indicated resources, economics, environmental, tax efficiency, development and the potential for pilot and eventual commercial production at the Pocitos 1 lithium project (“Pocitos 1”). Upon completion of the option of the Candela II project on Salar de Incahuasi the Company will register an additional Argentina subsidiary to hold...

Continue reading

DNA Plc is restructuring its network infrastructure

DNA PLC STOCK EXCHANGE RELEASE 3 JULY 2024 AT 15:20 EEST DNA Plc’s Finnish network infrastructure business, which is conducted by the company’s subsidiary, DNA Tower Finland Oy, is being transferred to a limited company that is to be founded as part of DNA’s partial demerger, Telenor Towers Finland Oy. The partial demerger is planned to take place on 31 December 2024. This is an internal restructuring within Telenor Group and will not impact DNA’s operations. Media enquiries:DNA Corporate Communications, tel. +358 44 044 8000, communications@dna.fi DNA is one of the leading telecommunications companies in Finland. Our mission is to connect you to what matters most. We offer connections, services and devices for homes and workplaces, contributing to the digitalisation of society. DNA’s customers have been among the most active users of...

Continue reading

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Following the Company’s recent FDA approval to commence its pivotal human clinical trial, Baptist Hospital of Miami is the second clinical site to enroll in the trial BRAINTREE, Mass., July 03, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces it has received Institutional Review Board approval and signed a Clinical Trial Agreement with Baptist Hospital of Miami, which includes Miami Cardiac & Vascular Institute and Miami Cancer Institute.   This is the second announced site that will participate in the clinical trial for Microbot’s LIBERTY as part of its Investigational Device Exemption (“IDE”).   The Company had recently announced Brigham and Women’s Hospital as another participating site. The principal investigator...

Continue reading

Form 8.3 – [MATTIOLI WOODS PLC – 02 07 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree MATTIOLI WOODS PLC (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: MATTIOLI WOODS PLC AS AN ASSOCIATE...

Continue reading

Form 8.3 – [KEYWORDS STUDIOS PLC – 02 07 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree KEYWORDS STUDIOS PLC (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A (e)   Date position...

Continue reading

Constellation Brands Reports First Quarter Fiscal 2025 Financial Results

ROCHESTER, N.Y., July 03, 2024 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its first quarter fiscal 2025 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Chief Financial Officer, Garth Hankinson, on Wednesday, July 3, 2024 at 10:30 a.m. EDT. Visit ir.cbrands.com to locate information for joining the conference call, or a live, listen-only webcast of the conference call. ABOUT CONSTELLATION BRANDSConstellation Brands (NYSE: STZ) is a leading international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Our mission is to build brands that people love because we believe elevating human connections...

Continue reading

TFI International to Release 2024 Second Quarter Results

MONTREAL, July 03, 2024 (GLOBE NEWSWIRE) — TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, today announced that it will release its financial results for the second quarter ended June 30, 2024 via news release on Thursday, July 25, 2024 after market close. The company will host a webcast with Alain Bédard, Chairman, President and Chief Executive Officer, on Friday, July 26, 2024 at 8:30 AM Eastern Time, to discuss results. Webcast Details: Date: Friday, July 26, 2024 Time: 8:30 a.m. Eastern Time Live webcast & replay: Presentations & Reports within the Investors section of the Company website ABOUT TFI INTERNATIONALTFI International Inc. is a North American leader in the transportation and logistics industry, operating across the United States, Canada...

Continue reading

Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical Results

Company to Host Webcast on 12th July at 9am AEST (7pm ET, 11 July) SYDNEY, AUSTRALIA, July 03, 2024 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces details for an upcoming oral presentation at the European Society for Medical Oncology (ESMO) Virtual Plenary session on July 11, 2024, featuring new clinical data in patients with negative PD-L1 expression (Cohort B) in the TACTI-003 (KEYNOTE-PNC-34) Phase IIb trial, and a webcast to discuss these clinical results. ESMO Virtual Plenaries are monthly presentations of the latest, original scientific data, including “Phase II trials which demonstrate remarkable therapeutic benefit, scientific insight or progress in an...

Continue reading

Terra Balcanica Signs Definitive Agreement to Acquire Saskatchewan Uranium Assets

Vancouver, British Columbia, July 03, 2024 (GLOBE NEWSWIRE) — Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1), a multi-jurisdictional, polymetallic exploration company focused on supporting the global transition to clean energy, is pleased to announce the signing of the definitive option agreement dated July 2, 2024 (“Agreement”) between the Company, Fulcrum Metals Plc. (“Fulcrum”, AIM:FMET) and Fulcrum Metals (Canada) Ltd. (“Fulcrum Canada”), a wholly-owned subsidiary of Fulcrum, pursuant to which the Company will obtain a four-year option (the “Option”) to acquire a 100% interest in Fulcrum’s uranium portfolio of exploration licences (the “Licences”) located in northern Saskatchewan, Canada and collectively encompassing 596.71 km2 of highly prospective ground for a uranium discovery. Pursuant to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.